Skip to search formSkip to main contentSkip to account menu

ODF4 gene

Known as: CT136, cancer/testis antigen 136, ODF4 
National Institutes of Health

Related topics

Related topics

2 relations
ODF2 geneODF3 gene

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Abstract CT136: Phase Ib study of Decitabine in combination with Gemcitabine in treatment of refractory pancreatic adenocarcinoma and advanced soft tissue or bone sarcomas
Background and Objectives: Metastatic pancreatic adenocarcinoma is the second leading cause of cancer related death in the US… 
2016
2016
The Expression of Cancer/Testis Antigens in Kidney and Bladder Malignancies
Background: Cancer/testis antigens (CTA) are aberrantly expressed in various tumors, including urologic malignancies. Decreased… 
2015
2015
Abstract CT136: Final biomarker analysis of the phase I study of the selective BRAF V600 inhibitor encorafenib (LGX818) combined with cetuximab with or without the α-specific PI3K inhibitor alpelisib…
Background: Although BRAF V600-mutated (BRAFm) colorectal carcinoma (CRC) does not generally respond to BRAF inhibitors, results… 
2005
2005
Surface Modification of CT136 to Superfine Alumina Powder
Surface Modification is not only one of the most important methods to change normal inorganic fillers to functional fillers, but… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)